PTCA Catheter Downclassification Carries Unresolved Safety Issues - Panel
This article was originally published in The Gray Sheet
Executive Summary
Postmarket surveillance requirements should be part of any decision to downclassify percutaneous transluminal coronary angioplasty (PTCA) balloon catheters from Class III to Class II, according to FDA's Circulatory System Devices Panel.
You may also be interested in...
Balloon Angioplasty Catheters Gain Quicker Path To Market Under FDA Rule
Standard balloon-tipped angioplasty catheters can enter the market through the 510(k) clearance process, rather than the PMA route, beginning next month
Balloon Angioplasty Catheters Gain Quicker Path To Market Under FDA Rule
Standard balloon-tipped angioplasty catheters can enter the market through the 510(k) clearance process, rather than the PMA route, beginning next month
Balloon Catheters Might Finally Be Moved Down To 510(k) Status, FDA Signals
FDA says most standard balloon angioplasty catheters should be allowed on the market with 510(k)s rather than the current PMA standard